Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy

被引:1127
|
作者
Delettre, C
Lenaers, G
Griffoin, JM
Gigarel, N
Lorenzo, C
Belenguer, P
Pelloquin, L
Grosgeorge, J
Turc-Carel, C
Perret, E
Astarie-Dequeker, C
Lasquellec, L
Arnaud, B
Ducommun, B
Kaplan, J
Hamel, CP [1 ]
机构
[1] INSERM, U254, Lab Neurobiol Audit, Montpellier, France
[2] Univ Toulouse 3, Lab Biol Cellulaire & Mol Controle Proliferat, CNRS, UMR 5088, F-31062 Toulouse, France
[3] Hop Necker Enfants Malad, INSERM, U393, Paris, France
[4] Fac Med, CNRS, UNSA, UMR 6549, Nice, France
[5] Sanofi Synthelabo, Labege, France
[6] Inst Pharmacol & Biol Struct, CNRS, UPR 9062, Toulouse, France
[7] Hop Gui Chauliac, Serv Ophthalmol, Montpellier, France
关键词
D O I
10.1038/79936
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Optic: atrophy type 1 (OPA1. MIM 165500) is a dominantly inherited optic neuropathy occurring in 1 in 50.000 individuals(1-3) that features progressive loss in visual acuity leading, in many cases, to legal blindness(4-8). Phenotypic variations(5) and loss of retinal ganglion cells(9,10), as found in Leber hereditary optic neuropathy (LHON), have suggested possible mitochondrial impairment(11,12). The OPA1 gene has been localized to 3q28-q29 (refs 13-19). We describe here a nuclear gene, OPA1, that maps within the candidate region and encodes a dynamin-related protein localized to mitochondria. We found four different OPA1 mutations, including frameshift and missense mutations, to segregate with the disease, demonstrating a role for mitochondria in retinal ganglion cell pathophysiology.
引用
收藏
页码:207 / 210
页数:4
相关论文
共 50 条
  • [21] Dominant (Kjer's) optic atrophy associated with mutations in OPA1 gene
    Kelifova, S.
    Honzik, T.
    Tesarova, M.
    Kousal, B.
    Liskova, P.
    Havrankova, P.
    Kolarova, H.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (01) : 33 - 42
  • [22] Mitochondrial disorder with OPA1 mutation and no optic atrophy
    Milone, M.
    Younge, B.
    Wang, J.
    Zhang, S.
    Wong, L-J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 204 - 204
  • [23] Dominant Optic Atrophy (DOA): Modeling the Kaleidoscopic Roles of OPA1 in Mitochondrial Homeostasis
    Del Dotto, Valentina
    Carelli, Valerio
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [24] The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space
    Olichon, A
    Emorine, LJ
    Descoins, E
    Pelloquin, L
    Brichese, L
    Gas, N
    Guillou, E
    Delettre, C
    Valette, A
    Hamel, CP
    Ducommun, B
    Lenaers, G
    Belenguer, P
    FEBS LETTERS, 2002, 523 (1-3) : 171 - 176
  • [25] Mutation screenings of OPA1 in dominant optic atrophy.
    Murton, NJ
    Toomes, C
    Mackey, DA
    Inglehearn, CF
    Churchill, AJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S650 - S650
  • [26] New insights into OPA1 autosomal dominant optic atrophy
    Whitehead, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [27] OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
    Wong, David C. S.
    Harvey, Joshua P.
    Jurkute, Neringa
    Thomasy, Sara M.
    Moosajee, Mariya
    Yu-Wai-Man, Patrick
    Gilhooley, Michael J.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2023, 43 (04) : 464 - 474
  • [28] AAV Gene Therapy for Autosomal Dominant Optic Atrophy Caused by Mutation in the Opa1 Gene
    Stupay, Rachel M.
    Cascone, Alyna
    Padegimas, Linas
    Wille, Paul T.
    Kevany, Brian M.
    MOLECULAR THERAPY, 2023, 31 (04) : 696 - 697
  • [29] A novel mutation of the OPA1 gene in a Japanese patient with autosomal dominant optic atrophy
    Ban, Yuriko
    Yoshida, Yusuke
    Kawasaki, Satoshi
    Mochida, Chikako
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (10) : 1581 - 1583
  • [30] A novel mutation of the OPA1 gene in a Japanese patient with autosomal dominant optic atrophy
    Yuriko Ban
    Yusuke Yoshida
    Satoshi Kawasaki
    Chikako Mochida
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 1581 - 1583